Viewing Study NCT00270556


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2025-12-25 @ 8:54 PM
Study NCT ID: NCT00270556
Status: COMPLETED
Last Update Posted: 2008-04-10
First Post: 2005-12-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module